Food allergy affects 1 in 13 children, and a growing number of adults in the U.S. Children
with reported food allergy are also two to four times more likely to have
other related conditions such as asthma and other inhalant allergies compared
to children without food allergy. (Branum et al., 2008).
Of increasing concern is that the prevalence of reported food allergy continues to increase at a rapid rate.
Treatment protocol is for adults too!
Currently, the standard of care for food allergy is limited to strict avoidance
of food allergens and ready access to self-injectable epinephrine.
Despite everyone’s best efforts, accidental exposures can and do occur.
This difficulty in avoiding food allergens and the potential for sudden and
life threatening reactions can diminish health-related quality of life for patients and their families.
(Burks, Laubach, and Jones, 2008).
The goal of sublingual immunotherapy for food allergies is to reduce the risk
of reactions in case of accidental exposure, and ultimately to help build a
tolerance to the foods one is allergic to.
The treatment approach takes advantage of the special properties
of the sublingual area: a high number of dendritic cells,
a low number of mast cells, and rapid access to regional lymph nodes.
We offer multi-allergen food threshold treatment
using the La Crosse Method™ Protocol.
Food allergy treatment can be provided to patients who test positive
for food allergies, and most often prescribed in conjunction with inhalant allergy drops.
The treatment level for food allergy drops is based on the individual patient’s blood test results.
Treatment levels are gradually increased as the patient’s test results show improvement.
Patients take a dose three times daily using a metered dispenser.
One bottle lasts 90 days.